Patents Represented by Attorney, Agent or Law Firm Hunton & Williams
  • Patent number: 8121871
    Abstract: The present invention relates generally to systems, methods and software applications for storing, retrieving, and displaying information. More particularly, the present invention relates to providing a comprehensive, interactive tool for storing, retrieving, and displaying agent identifying information and agent commission information. The method of the present invention comprises the steps of: receiving agent identifying information and agent commission information; analyzing and sorting the received agent identifying information and agent commission information; saving the agent identifying information and the agent commission information; providing an interactive display of the agent identifying information and the agent commission information; providing interactive access to a display of detailed agent identifying information; and providing interactive access to a display of detailed agent commission information.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: February 21, 2012
    Assignee: Genworth Financial, Inc.
    Inventors: Freeland Glen Young, III, Liane Dietrich, Diana H. Garland, Lee Edwards
  • Patent number: 8119359
    Abstract: Newly identified mammalian taste-cell-specific G protein-coupled receptors which function as hetero-oligomeric complexes in the sweet taste transduction pathway, and the genes and cDNA encoding said receptors are described. Specifically, T1R G protein-coupled receptors active in sweet taste signaling as hetero-oligomeric complexes, and the genes and cDNA encoding the same, are described, along with methods for isolating such genes and for isolating and expressing such receptors. Methods for identifying putative taste modulating compounds using such hetero-oligomeric complexes also described, as is a novel surface expression facilitating peptide useful for targeting integral plasma membrane proteins to the surface of a cell.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: February 21, 2012
    Assignee: Senomyx, Inc.
    Inventors: Jon E. Adler, Xiaodong Li, Lena Staszewski, Hong Xu, Fernando Echeverri
  • Patent number: 8119134
    Abstract: A composition is provided to prevent, limit the effects of, delay the onset of, or treat one or more of the causes, symptoms or complications of gestational hypertension, preeclampsia, eclampsia and/or intrauterine growth restriction. The composition comprises a therapeutically effective amount of an antibody that reacts immunologically with or binds digoxin and has a high dose of digoxin binding capacity as the active ingredient. There is also provided a method of preventing, limiting the effects of, delaying the onset of, or treating a cause, symptom or complication of gestational hypertension, preeclampsia, eclampsia or intrauterine growth restriction, comprising the step of administering to a mammal a composition comprising a therapeutically effective amount of an antibody that reacts immunologically with or binds digoxin and has a high dose of digoxin binding capacity.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: February 21, 2012
    Assignee: Glenveigh Pharmaceuticals, LLC
    Inventor: Charles David Adair
  • Patent number: 8116551
    Abstract: The present invention relates generally to a method for determining the level of expression of one or more candidate objects of interest in a biological sample. In particular, the present invention relates to a method for determining the level of expression of one or more candidate objects of interest using image analysis. More specifically, the present invention relates to a method and a system for determining the level of expression of one or more candidate objects of interest using an automated (computer-aided) image analysis system.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: February 14, 2012
    Assignee: University College, Dublin, National University of Ireland
    Inventors: William Gallagher, Elton Rexhepaj, Donal Brennan
  • Patent number: 8114426
    Abstract: A composition comprising herbicidal mixtures of mesotrione impregnated into or coated on the surface of a granular substrate material such as a fertilizer granule and/or a solid inert carrier material is provided for use to control weeds in turfgrasses without causing damage to the grass and methods for the use thereof.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: February 14, 2012
    Assignee: OMS Investments, Inc.
    Inventor: Robert D. Baker
  • Patent number: 8114867
    Abstract: The invention relates to antibacterial compounds of formula I wherein R1 is hydrogen, halogen, hydroxy, alkoxy or cyano; Y1 and Y2 each represent CH, one or two of U, V, W and X represent(s) N and the remaining each represent CH or, in the case of X, may also represent CRa, Ra being halogen, and, in the case of W, may also represent CRb, or each of U, V, W, X, Y1 and Y2 represents CH, or each of U, V, W, X and Y1 represents CH and Y2 represents N, or also one or, provided R1 is hydrogen, two of U, V, W, X, Y1 and Y2 represent(s) CRC and the remaining each represent CH, Rb being alkoxy, alkoxycarbonyl or alkoxyalkoxy and Rc being, each time it occurs, independently represents hydroxy or alkoxy; A-B-D represents a chain of 4 to 6 atoms, which 4 to 6 atoms are selected from carbon, oxygen and nitrogen and may be substituted; E is one of the following groups: in which Z is CH or N and Q is O or S, or E is a phenyl group which is substituted once or twice in the meta and/or para position(s); and to salts
    Type: Grant
    Filed: April 10, 2008
    Date of Patent: February 14, 2012
    Assignee: Actelion Pharmaceuticals Ltd
    Inventors: Markus Gude, Christian Hubschwerlen, Georg Rueedi, Jean-Philippe Surivet, Cornelia Zumbrunn-Acklin
  • Patent number: 8110713
    Abstract: The present invention relates to a process for producing pentafluoroethane. More particularly, the subject of the invention is a continuous process for producing pentafluoroethane comprising (i) a step of fluorinating perchloroethylene (PER) with hydrofluoric acid, in the gas phase, in the presence of a catalyst, (ii) a step of separating the products issuing from step (i) in order to give a fraction of light products and a fraction of heavy products, comprising hydrofluoric acid, unreacted perchloroethylene and under-fluorinated products, and (iii) a step of pretreating the fraction of heavy products before recycling to step (i).
    Type: Grant
    Filed: May 21, 2007
    Date of Patent: February 7, 2012
    Assignee: Arkema France
    Inventors: Béatrice Boussand, Sylvain Perdrieux
  • Patent number: 8110574
    Abstract: A subject of the present application is new derivatives of 4-aminopiperidines of formula in which R1, R2 and R3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: February 7, 2012
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Christophe Thurieau, Jérôme Gonzalez, Christophe Moinet
  • Patent number: 8110199
    Abstract: Protein antigens from Streptococcus pneumoniae are disclosed, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: February 7, 2012
    Assignee: Sanofi Pasteur Limited
    Inventors: Christophe François Guy Gilbert, Philip Michael Hansbro
  • Patent number: 8105792
    Abstract: In one aspect, the present invention relates to a mammalian cell-based high-throughput assay for the profiling and screening of human epithelial sodium channel (hENaC) cloned from a human kidney c-DNA library and is also expressed in other tissues including human taste tissue. The present invention further relates to amphibian oocyte-based medium-throughput electrophysiological assays for identifying human ENaC modulators, preferably ENaC enhancers. Compounds that modulate ENaC function in a cell-based ENaC assay are expected to affect salty taste in humans. The assays described herein have advantages over existing cellular expression systems. In the case of mammalian cells, such assays can be run in standard 96 or 384 well culture plates in high-throughput mode with enhanced assay results being achieved by the use of a compound that inhibits ENaC function, preferably an amiloride derivative such as Phenamil.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: January 31, 2012
    Assignee: Senomyx, Inc.
    Inventors: Guy Servant, Hong Chang, Cyril Redcrow, Sumita Ray, Imran Clark, Bryan Moyer
  • Patent number: 8105124
    Abstract: A device and method for recovering articles inadvertently submerged in a body of water are disclosed. The device comprises a housing attachable to the article, the housing defining a storage chamber with a storage chamber opening at one end. The storage chamber contains a buoyant flotation element held in the storage chamber by a water-activated release mechanism that permits the flotation element to move toward and through the storage chamber opening when the device is submerged in water. The flotation element remains connected to the housing by a connection mechanism. The device housing also may include a biasing mechanism configured to bias the flotation element toward the storage chamber opening. The method includes attaching the housing to the article to be retrieved, having the flotation element release from the housing and float to the surface of the water and following the connection mechanism from the flotation element to the housing.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: January 31, 2012
    Inventor: Patrick Brent Williams
  • Patent number: 8106256
    Abstract: The present invention relates to plant cells and plants which synthesize an increased amount of hyaluronan, and to methods for preparing such plants, and also to methods for preparing hyaluronan with the aid of these plant cells or plants. Here, plant cells or genetically modified plants according to the invention have hyaluronan synthase activity and additionally an increased glutamine:fructose 6-phosphate amidotransferase (GFAT) activity and an increased UDP glucose dehydrogenase (UDP-Glc-DH) activity, compared to wild-type plant cells or wild-type plants. The present invention furthermore relates to the use of plants having increased hyaluronan synthesis for preparing hyaluronan and food or feedstuff containing hyaluronan.
    Type: Grant
    Filed: October 5, 2006
    Date of Patent: January 31, 2012
    Assignee: Bayer Cropscience AG
    Inventors: Claus Frohberg, Bernd Essigmann
  • Patent number: 8104076
    Abstract: A system for application access control is disclosed. First. a business coordinator needs to register a user developed tool (UDT) containing an application to be protected with the system via a software program. After registration. a random encrypted password is generated by the application access control server and stored in its back-end database as well as a local break-glass database corresponding to the UDT. When an entitled user accesses the application in the registered UDT later on, the system will check whether he/she is entitled to access the requested application. If yes. the system will retrieve the encrypted password for that application and thus launch the application.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: January 24, 2012
    Assignee: JPMorgan Chase Bank, N.A.
    Inventors: Josiah Lam, Mark D. McGovern
  • Patent number: 8102730
    Abstract: A signaling system includes a signaling path, a master device coupled to the signaling path, a slave device coupled to the signaling path, and a clock generator. The slave device includes timing circuitry to generate an internal clock signal having a phase offset relative to a clock signal supplied by the clock generator, the phase offset being determined at least in part by a signal propagation time on the signal path.
    Type: Grant
    Filed: February 16, 2010
    Date of Patent: January 24, 2012
    Assignee: Rambus, Inc.
    Inventor: Donald C. Stark
  • Patent number: 8098916
    Abstract: A system and method for image-based correction including a receiver to acquire an image from one or more data storage systems, one or more processors to determine an attenuation mismatch estimate and calculate a correction for the image based on the attenuation mismatch estimate and the image, and an output to generate an attenuation mismatch corrected image based on the correction.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: January 17, 2012
    Assignee: General Electric Company
    Inventors: Kris Flip Johan Jules Thielemans, Alexander Ganin, Evren Asma, Ravindra Mohan Manjeshwar
  • Patent number: D653083
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: January 31, 2012
    Assignee: Masterbuilt Manufacturing, Inc.
    Inventors: Ashley Hatcher, B. Seth Sawyer
  • Patent number: D653263
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: January 31, 2012
    Assignee: Holley Performance Products, Inc.
    Inventors: Amy Gieske, Laura Shehan, Shane Weckerly
  • Patent number: D653676
    Type: Grant
    Filed: March 3, 2011
    Date of Patent: February 7, 2012
    Assignee: Holley Performance Products, Inc.
    Inventors: Thomas Tomlinson, Shane Weckerly, Kevin Tracy, Coy Allen Hudnall
  • Patent number: D654094
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: February 14, 2012
    Assignee: Holley Performance Products, Inc.
    Inventor: James D. Dralle
  • Patent number: D654235
    Type: Grant
    Filed: March 1, 2010
    Date of Patent: February 14, 2012
    Assignee: Electrolux Home Care Products, Inc.
    Inventors: Brian Wang Sun, John Morphey, Randall Sandlin, Vincent Bobrosky